News
Retreatment With High-Dose Rituximab Reduced DAS28 Levels
Major Finding: In patients with rheumatoid arthritis, initial treatment with rituximab 500 mg x 2 or 1,000 mg x 2 led to comparable clinical...
News
Two Biomarkers Predict Response to Rituximab in RA
Major Finding: Continued response to rituximab in patients with RA after 6 months of therapy can be predicted by B-cell repopulation and...
News
Seropositivity Predicts Good Response to Rituximab in RA
Major Finding: Patients with rheumatoid arthritis who are seropositive achieve significantly greater reductions in DAS28 at 6 months than do those...
News
Early Detection of Scleroderma-Associated PAH Enhanced Survival
Major Finding: Survival at 1 and 3 years was 93% and 75% in patients whose incident systemic sclerosis–associated pulmonary arterial hypertension...
News
Program Strikes Early at Major Psychiatric Disorders
Major Finding: Therapeutic intervention for schizophrenia, bipolar disorder, and major depressive disorder is most effective when done early and...